Severity
Moderate
FDA Drug recall · Reported April 25, 2018
Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
Partell Specialty Pharmacy recalled Estradiol 50 mg (SD) pellets in amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. … - a moderate-severity action.
Estradiol 50 mg (SD) pellets in amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. … was recalled by Partell Specialty Pharmacy in April 25, 2018. Reason: Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of steriliz…. Check the official notice for the remedy. Verify recall #D-0680-2018 with the FDA Drug before acting.
The recall
Partell Specialty Pharmacy issued this moderate-severity FDA Drug recall-Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of steriliz….
Sourced from official FDA Drug enforcement records. Verify recall #D-0680-2018 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0680-2018) was formally reported on April 25, 2018, with the manufacturer initiating the action on March 22, 2018. It is classified under Moderate severity (Class II), with a current status of Terminated. Partell Specialty Pharmacy is listed as the recalling firm, operating out of Las Vegas, NV. The number of affected units is not disclosed in the agency filing, which is common for drug and food recalls where lot-level tracking supersedes unit counts.
The documented reason for this recall is: Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization. Distribution data in the federal record shows the product reached: NV only. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 6 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,436 drugs & medications recalls on record
Of 88,001 recalls with an agency hazard classification, 19,020 are high severity, 64,468 moderate, and 4,513 low. A further 16,157 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
Unknown
Related Recalls
6
6 from same agency
Estradiol 50 mg (SD) pellets in amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800.
Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-0680-2018 |
| Date reported | April 25, 2018 |
| Date initiated | March 22, 2018 |
| Recalling firm | Partell Specialty Pharmacy |
| Firm location | Las Vegas, NV |
| Affected scope | Not disclosed |
| Distribution | NV only |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Two federal-filing-derived peer sets for this notice, both outside the same recalling firm and filing state so the neighborhoods are not firm or geographic containment.
Same archive severity grade (Moderate), closest by report date among other firms and states.
Same product category, closest by report date among other firms and states (deduped against the severity set).
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
Showing 5 of 14436 other recalls in this category.
Rohto-Mentholatum (Vietnam) Co., Ltd. · 2026-07-29
Major Pharmaceuticals · 2026-07-29
Rohto-Mentholatum (Vietnam) Co., Ltd. · 2026-07-29
Major Pharmaceuticals · 2026-07-29
Major Pharmaceuticals · 2026-07-29
Compare this recall with Rohto Cooling Eye Drops Max Strength (naphazoline hydrochlo… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported April 25, 2018. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.